₹408.3
▼ -2.63 -0.64%
As of 27 Jul 2026 · delayed
NSE Listed
Aarti Drugs Ltd. (AARTIDRUGS)
Volume: 83,430Avg Vol 1W: 1,41,046.8Avg Vol 1M: 2,17,427.852W Range:₹318.95₹549.3
Key Ratios
Checked 1d agoMarket Cap₹3,743 Cr
Current Price₹408.3
Previous Close₹410.93
High / Low (52w)₹549.3 / ₹318.95
Volume83,430
Avg Vol (1W)1,41,046.8
Avg Vol (1M)2,17,427.8
Stock P/E67.79
Book Value₹169.7
Dividend Yield0.5%
ROE12.6%
ROA6.9%
Revenue (TTM)₹2,403 Cr
Revenue Growth-5.6%
Profit Margin7.6%
Total Debt₹284 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹6.05
P/B2.42
Debt / Equity0.37
50 DMA₹386.74
200 DMA₹394.21
Day change-0.64%
Price Chart
₹408.3▼ 24.26% · 1Y
2025-07-292026-07-27
20-day avg volume: 2.2L shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 20% YoY.
- Stock trades at a high P/E of 68.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹555 Cr | ₹598 Cr | ₹557 Cr | ₹677 Cr | ₹591 Cr | ₹653 Cr | ₹602 Cr | ₹720 Cr |
| EBITDA | ₹53 Cr | ₹55 Cr | ₹60 Cr | ₹80 Cr | ₹60 Cr | ₹68 Cr | ₹38 Cr | ₹79 Cr |
| Net Profit | ₹33 Cr | ₹35 Cr | ₹37 Cr | ₹63 Cr | ₹54 Cr | ₹45 Cr | ₹41 Cr | ₹55 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹543 Cr | ₹515 Cr | ₹623 Cr | ₹2,403 Cr | ₹521 Cr | ₹579 Cr | ₹529 Cr | ₹632 Cr |
| EBITDA | ₹48 Cr | ₹60 Cr | ₹78 Cr | ₹248 Cr | ₹52 Cr | ₹62 Cr | ₹29 Cr | ₹65 Cr |
| Net Profit | ₹30 Cr | ₹39 Cr | ₹61 Cr | ₹168 Cr | ₹49 Cr | ₹42 Cr | ₹34 Cr | ₹45 Cr |
| EPS | — | — | — | 18.42 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,389 Cr | ₹1,455 Cr | ₹1,577 Cr | ₹1,766 Cr | ₹2,208 Cr | ₹2,421 Cr | ₹2,432 Cr | ₹2,575 Cr |
| Total Liabilities | ₹934 Cr | ₹912 Cr | ₹924 Cr | ₹853 Cr | ₹1,172 Cr | ₹1,229 Cr | ₹1,150 Cr | ₹1,205 Cr |
| Equity | ₹455 Cr | ₹543 Cr | ₹652 Cr | ₹913 Cr | ₹1,036 Cr | ₹1,193 Cr | ₹1,282 Cr | ₹1,369 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹94 Cr | ₹173 Cr | ₹292 Cr | ₹252 Cr | ₹154 Cr | ₹193 Cr | ₹421 Cr | ₹300 Cr |
| Investing | ₹-74 Cr | ₹-62 Cr | ₹-33 Cr | ₹-72 Cr | ₹-150 Cr | ₹-164 Cr | ₹-224 Cr | ₹-165 Cr |
| Financing | ₹4 Cr | ₹-80 Cr | ₹-215 Cr | ₹-81 Cr | ₹92 Cr | ₹17 Cr | ₹-136 Cr | ₹-82 Cr |
| Free Cash Flow | ₹94 Cr | ₹173 Cr | ₹292 Cr | ₹252 Cr | ₹154 Cr | ₹193 Cr | ₹421 Cr | ₹300 Cr |
Shareholding
Promoter 54.43% Institutions 11.82% Public 33.75%
Efficiency & Working Capital
ROCE13.1%
Interest Coverage6.4
Dividend Payout—
Debtor Days115 d
Inventory Days72 d
Payable Days64 d
Cash Conversion Cycle124 d
Working Capital Days187 d
Shareholding Details
As of 2026-06-30
Promoter54.4%
FII1.5%
DII10.3%
Institutions11.8%
Public33.7%
Promoter Pledge2.5%
No. of Shareholders1,43,476
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 58.6% | 57.5% | 57.1% | 55.7% | 55.6% | 55.4% | 55.5% | 55.2% | 54.7% | 55% | 55% | 54.4% |
| FIIs | 2.3% | 2.1% | 2.6% | 3% | 2.5% | 2.3% | 2.2% | 2.3% | 2.7% | 2.2% | 1.6% | 1.5% |
| DIIs | 5.3% | 5.3% | 6% | 7.4% | 7.8% | 8.8% | 9.7% | 9.9% | 9.9% | 10.1% | 10.2% | 10.3% |
| Public | 33.8% | 35.2% | 34.3% | 34% | 34% | 33.6% | 32.6% | 32.6% | 32.7% | 32.7% | 33.2% | 33.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 2.5% | 2.5% |
| No. of Shareholders | 1,67,446 | 1,70,414 | 1,57,547 | 1,50,218 | 1,90,281 | 1,76,006 | 1,69,761 | 1,60,260 | 1,52,252 | 1,48,363 | 1,44,946 | 1,43,476 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Prakash Moreshwar Patil | Shareholding of Promoter and Promoter Group | 9.6% | 87,83,869 |
| Dsp Small Cap Fund | Public Shareholding | 7.9% | 72,39,877 |
| Harshit Manilal Savla | Shareholding of Promoter and Promoter Group | 4.7% | 43,18,269 |
| Rashesh Chandrakant Gogri | Shareholding of Promoter and Promoter Group | 4.6% | 42,38,874 |
| Priti Prakash Patil | Shareholding of Promoter and Promoter Group | 4.4% | 40,16,315 |
| Seema Harshit Savla | Shareholding of Promoter and Promoter Group | 3.8% | 34,97,175 |
| Gogri Finserv Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 3.8% | 34,63,971 |
| Hetal Gogri Gala | Shareholding of Promoter and Promoter Group | 3.1% | 27,87,240 |
| Harit Pragji Shah | Public Shareholding | 2.7% | 24,36,908 |
| Anushakti Enterprise Private Limited | Shareholding of Promoter and Promoter Group | 2.6% | 23,92,696 |
| Alchemie Finserv Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.2% | 20,13,410 |
| Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund | Public Shareholding | 2% | 18,65,432 |
| Chandrakant Vallabhaji Gogri | Shareholding of Promoter and Promoter Group | 1.9% | 17,10,097 |
| Jayshree Harit Shah | Public Shareholding | 1.8% | 16,29,076 |
| Jaya Chandrakant Gogri | Shareholding of Promoter and Promoter Group | 1.7% | 15,64,023 |
| Aashyav Business Trust (alabhya Trusteeship Private Limited) | Shareholding of Promoter and Promoter Group | 1.5% | 13,68,429 |
| Adhish P. Patil | Shareholding of Promoter and Promoter Group | 1.3% | 11,41,079 |
| Bhoomi Harshit Savla | Shareholding of Promoter and Promoter Group | 1.1% | 9,95,164 |
| Vishwa Harshit Savla | Shareholding of Promoter and Promoter Group | 1% | 9,39,907 |
| Aashay Rashesh Gogri | Shareholding of Promoter and Promoter Group | 1% | 8,75,891 |
| Mirik Rajendra Gogri | Shareholding of Promoter and Promoter Group | 0.7% | 6,41,814 |
| Renil Rajendra Gogri | Shareholding of Promoter and Promoter Group | 0.7% | 5,97,957 |
| Paridhi Business Trust (saswat Trusteeship Private Limited) | Shareholding of Promoter and Promoter Group | 0.6% | 5,86,471 |
| Tulip Family Trust (gloire Trusteeship Services Private Limited | Shareholding of Promoter and Promoter Group | 0.5% | 4,74,636 |
| Jigna Hiren Shah | Shareholding of Promoter and Promoter Group | 0.5% | 4,52,597 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Mirik Rajendra Gogri | 6,41,814 | 100% | 2026-06-30 |
| Renil Rajendra Gogri | 5,97,957 | 100% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Prakash M Patil | CMD & Executive Director | 2025 |
| Rashesh C Gogri | ED / MD / Promoter | 2025 |
| Harshit M Savla | ED / Joint MD / Promoter | 2025 |
| Harit P Shah | E D & Wholetime Director | 2025 |
| Uday M Patil | WTD & Executive Director | 2025 |
| Narendra Jagannath Salvi | Non Executive Director | 2025 |
| Ankit Vikram Paleja | Independent Non Exe. Director | 2025 |
| Bhaskar Narayan Thorat | Independent Non Exe. Director | 2025 |
| Neha Gada | Independent Non Exe. Director | 2025 |
| Hasmukh Dedhia | Independent Non Exe. Director | 2025 |
| Sandeep Madhusudan Joshi | Independent Non Exe. Director | 2025 |
| Shri Ajit E. Venugopalan | Independent Non Exe. Director | 2025 |
| Rushikesh V Deole | Company Sec. & Compli. Officer | 2025 |
| Chandrakant V. Gogri | Chairman Emeritus | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing of API | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Out of India | ₹769 Cr | 35.4% |
| India | ₹1,404 Cr | 64.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 120 | 91 | 91 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-31 | Board Meetings | — |
| dividend | 2026-02-09 | ₹2 (20%) | Interim |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 55 | 0 | 0 | 17 | 21 | 93 |
| 2025 | 1 | 0 | 0 | 0 | 2 | 3 |
| 2025 | 36 | 0 | 0 | 0 | 0 | 36 |
Insider / Designated-Person Trades
25 recent disclosure(s)
Prakash Moreshwar PatilAcquisition · 50,000
Seema Harshit SavlaAcquisition · 11,000
Harshit Manilal SavlaAcquisition · 14,000
Renil Rajendra GogriDisposal · 1,64,500
Harit Pragji ShahAcquisition · 25,000
ALCHEMIE FINSERV PRIVATE LIMITEDAcquisition · 53,500
Substantial Acquisitions (SAST)
3 disclosure(s)
Market21/03/2025 · 19,575
Market22/12/2023 - 28/05/2024 · 18,38,118
Buy Back02/01/2024 · —
Company Information
🌐 www.aartidrugs.com ↗
📍 Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Aakash Exploration Services Ltd.Aaradhya Disposal Industries Ltd.Aarey Drugs & Pharmaceuticals Ltd.Aarnav Fashions LimitedAaron Industries LimitedAartech Solonics LimitedAarti Industries Ltd.Aarti Pharmalabs LimitedAarti Surfactants LimitedAarvi Encon LimitedAastha Spintex LimitedAatmaj Healthcare LimitedAll “A” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search